Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$5.4 - $13.37 $367,491 - $909,881
-68,054 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.91 - $14.7 $370,768 - $1.11 Million
-75,513 Reduced 52.6%
68,054 $463,000
Q4 2019

Feb 14, 2020

SELL
$9.77 - $15.66 $3.87 Million - $6.2 Million
-395,945 Reduced 73.39%
143,567 $2.14 Million
Q3 2019

Nov 14, 2019

SELL
$9.59 - $12.0 $1.3 Million - $1.63 Million
-135,488 Reduced 20.07%
539,512 $5.53 Million
Q4 2018

Feb 14, 2019

BUY
$8.63 - $12.4 $5.83 Million - $8.37 Million
675,000 New
675,000 $6.86 Million

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.